Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely hydrocortisone 25 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
Product containing precisely hydrocortisone probutate 1 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
hydrocortison 2 % |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
hydrocortisonacetat 0,5 % |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
hydrocortisonacetat 2,5 % creme |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
hydrocortisonnatriumsuccinat 1000 mg pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
hydrocortisonnatriumsuccinat 100 mg hætteglas pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
hydrocortisonnatriumsuccinat 500 mg pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
hydrocortisonacetat 2,5 % lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
hydrocortisonnatriumsuccinat 250 mg hætteglas pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
Product containing precisely hydrocortisone 5 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
Hydrocortisone 10 mg/mL cutaneous lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
Hydrocortisone 10 mg/mL eye solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
Product containing precisely hydrocortisone butyrate 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
Product containing precisely acetic acid 20 milligram/1 milliliter and hydrocortisone 10 milligram/1 milliliter conventional release ear solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
iseddikesyre + hydrocortison 2 % vægtvolumen/1 % vægtvolumen-opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
benzoylperoxid 50 mg + hydrocortison 5 mg lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
chloroxylenol 1 mg + hydrocortison 10 mg + pramoxinhydrochlorid 10 mg dråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
Ciprofloxacin hydrochloride + hydrocortisone 2.329mg/10mg suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
clioquinol + hydrocortison + pramoxinhydrochlorid 3 % wt/wt/1 % wt/wt/0,5 % wt/wt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
clioquinol 3 % wt/wt + hydrocortison 0,5 % wt/wt creme |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
clioquinol + hydrocortison 3 % wt/wt/0,5 % wt/wt lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
Clioquinol + hydrocortisone 30mg/10mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
colistinsulfat + hydrocortisonacetat + neomycinsulfat 3 mg/10 mg/3,3 mg opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
hexachlorophen 5 mg + hydrocortison 5 mg + mentol 1,25 mg creme til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
hydrocortison + neomycinsulfat + polymyxin B-sulfat 10 mg/5 mg/1,6 mg suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
hydrocortison + neomycinsulfat + polymyxin B-sulfat 10 mg/5 mg/10.000 opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
hydrocortison 10 mg + neomycinsulfat 3,5 mg + polymyxin B-sulfat 10.000 enheder suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
hydrocortison + neomycinsulfat + polymyxin B-sulfat 10 mg/7,5 mg/10.000 enheder suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
hydrocortison 10 mg + neomycinsulfat 7,5 mg + polymyxin B-sulfat 1.000 enheder opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
hydrocortison + polymyxin B 5 mg/10.000 enheder dråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
hydrocortisonacetat 5 mg + neomycinsulfat 3,5 mg + polymyxin B-sulfat 10.000 enheder creme |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
hydrocortisonacetat + pramoxinhydrochlorid 1 % wt/vol/1 % wt/vol lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
Clioquinol+flumethasone pivalate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
Product containing benzoyl peroxide and hydrocortisone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Product containing ascorbic acid and clioquinol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
colistinsulfat + hydrocortisonacetat + neomycinsulfat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
chloroxylenol + hydrocortison + pramoxinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
hydrocortison + neomycinsulfat + polymyxin B-sulfat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
ciprofloxacin 0,2 % + hydrocortison 1 % øreopløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
hydrocortisonacetat + neomycinsulfat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
Product containing diiodohydroxyquinoline and hydrocortisone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
clioquinol + hydrocortison + pramoxinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
hydrocortisonacetat 50 mg/ml injektionsvæske, suspension, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
hydrocortisonnatriumsuccinat 1000 mg pulver til injektionsvæske, hætteglas a 8 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
hydrocortisonacetat 50 mg/ml injektionsvæske, suspension, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
hydrocortisonnatriumsuccinat 500 mg pulver til injektionsvæske, hætteglas a 4 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
hydrocortison 1 % + pramocain 1 % skumklysma |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
hydrocortisonnatriumsuccinat 250 mg pulver til injektionsvæske, hætteglas, hætteglas a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
hydrocortisonnatriumphosphat 50 mg/ml injektionsvæske, opløsning, hætteglas a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
hydrocortisonnatriumsuccinat 100 mg pulver til injektionsvæske, hætteglas a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
Product containing precisely gentamicin (as gentamicin sulfate) 3 milligram/1 milliliter and hydrocortisone acetate 10 milligram/1 milliliter conventional release ear drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
hydrocortisonacetat + pramoxinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
fluocinolonacetonid 0,025 % + clioquinol 3 % creme |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
fluocinolonacetonid 0,025 % + clioquinol 3 % salve |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
hydrocortison 1 % vandig creme |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
hydrocortisonacetat + pramoxinhydrochlorid 1 % wt/wt/1 % wt/wt aerosol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
Hydrocortisone acetate 10 mg/mL and pramocaine hydrochloride 10 mg/mL cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
Product containing precisely hydrocortisone acetate 25 milligram/1 milliliter and pramocaine hydrochloride 10 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
hydrocortisonacetat + pramoxinhydrochlorid 2,5 % wt/wt/1 % wt/wt lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
hydrocortisonacetat 2,5 % wt/wt + pramoxinhydrochlorid 1 % wt/wt salve |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
Hydrocortisone cypionate |
Is a |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
Hydrocortisone sodium phosphate |
Is a |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
Hydrocortisone sodium succinate |
Is a |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
Hydrocortisone probutate |
Is a |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
Hydrocortisone butyrate |
Is a |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
Hydrocortisone valerate |
Is a |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
Hydrocortisone acetate |
Is a |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
ciprofloxacin + hydrocortison |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
Product containing acetic acid and hydrocortisone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
Product containing betamethasone and clioquinol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
Ciprofloxacin hydrochloride + hydrocortisone 2.329mg/10mg suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
Topical hydrocortisone adverse reaction |
Causative agent |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
bivirkning af kombinationspræparat med hydrocortison til topikal anvendelse |
Causative agent |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Allergy to hydrocortisone (finding) |
Causative agent |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
allergi over for hydrocortison til topikal anvendelse |
Causative agent |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
allergi over for kombinationspræparat med hydrocortison til topikal anvendelse |
Causative agent |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
Hydrocortisone adverse reaction (disorder) |
Causative agent |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
overfølsomhed over for hydrocortison |
Causative agent |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Product containing cinchocaine and hydrocortisone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
lignocain 5 % + hydrocortisonacetat 0,275 % salve |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
Product containing calamine and clioquinol and zinc oxide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
Free cortisol |
Is a |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
Cortisolderivat |
Is a |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
Serum cortisol |
Is a |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
Cortisol, free measurement |
Component |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
3 |
Cortisol, challenge tests (procedure) |
Component |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
9am cortisol measurement |
Component |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Midnight cortisol measurement |
Component |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Cortisol day curve |
Component |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Cosyntropin test |
Component |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Cortisol measurement, free, urine |
Component |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
4 |
Cortisol measurement |
Component |
True |
Hydrocortisone (substance) |
Inferred relationship |
Some |
1 |
Urine free cortisol 24 hour assay |
Component |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
|
Serum cortisol measurement |
Component |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
Urine cortisol titer measurement |
Component |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
Plasma cortisol measurement |
Component |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
24 hour urine cortisol output measurement |
Component |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
2 |
30 minute serum cortisol measurement |
Component |
False |
Hydrocortisone (substance) |
Inferred relationship |
Some |
3 |